Generate Biomedicines, Inc. (GENB)
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States.
$14.02-0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+10.8%
The outlook
Generate Biomedicines, Inc. currently reads as neutral based on mixed vs its moving averages, 42% of the way from its 52-week low to high, avg target +81% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range42% of the way from its 52-week low to high
Price targetAvg target +81% vs current price
Analyst price target
~12-month · 5 analysts$25.40average target+81.2% vs now
Now $14.02
Low $22.00High $30.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.80B
52-wk high
$18.18
52-wk low
$11.00
50-day avg
$14.24
200-day avg
$13.50
Trailing P/E
—